The recent surge in investments into boutique pharmaceutical companies, particularly those focusing on experimental therapies and complex drug development programs, has fueled what some are calling "High Roller https://nanniezybg298609.thekatyblog.com/38436538/high-investor-pharma-the-hazardous-bet